BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 26980748)

  • 1. Whole transcriptome profiling of patient-derived xenograft models as a tool to identify both tumor and stromal specific biomarkers.
    Bradford JR; Wappett M; Beran G; Logie A; Delpuech O; Brown H; Boros J; Camp NJ; McEwen R; Mazzola AM; D'Cruz C; Barry ST
    Oncotarget; 2016 Apr; 7(15):20773-87. PubMed ID: 26980748
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-grade serous tubo-ovarian cancer refined with single-cell RNA sequencing: specific cell subtypes influence survival and determine molecular subtype classification.
    Olbrecht S; Busschaert P; Qian J; Vanderstichele A; Loverix L; Van Gorp T; Van Nieuwenhuysen E; Han S; Van den Broeck A; Coosemans A; Van Rompuy AS; Lambrechts D; Vergote I
    Genome Med; 2021 Jul; 13(1):111. PubMed ID: 34238352
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decorin protein core affects the global gene expression profile of the tumor microenvironment in a triple-negative orthotopic breast carcinoma xenograft model.
    Buraschi S; Neill T; Owens RT; Iniguez LA; Purkins G; Vadigepalli R; Evans B; Schaefer L; Peiper SC; Wang ZX; Iozzo RV
    PLoS One; 2012; 7(9):e45559. PubMed ID: 23029096
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identifying biomarkers of breast cancer micrometastatic disease in bone marrow using a patient-derived xenograft mouse model.
    Pillai SG; Li S; Siddappa CM; Ellis MJ; Watson MA; Aft R
    Breast Cancer Res; 2018 Jan; 20(1):2. PubMed ID: 29291741
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Establishment and characterization of a non-gestational choriocarcinoma patient-derived xenograft model.
    Oda Y; Niimi K; Yoshida K; Tamauchi S; Yokoi A; Yasui Y; Nishiko Y; Shibata M; Shimizu Y; Yoshihara M; Ikeda Y; Yoshikawa N; Nishino K; Yamamoto E; Kajiyama H
    BMC Cancer; 2023 Nov; 23(1):1103. PubMed ID: 37957624
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decoding breast cancer tissue-stroma interactions using species-specific sequencing.
    Chivukula IV; Ramsköld D; Storvall H; Anderberg C; Jin S; Mamaeva V; Sahlgren C; Pietras K; Sandberg R; Lendahl U
    Breast Cancer Res; 2015 Aug; 17(1):109. PubMed ID: 26265142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radiogenomic analysis of cellular tumor-stroma heterogeneity as a prognostic predictor in breast cancer.
    Fan M; Wang K; Zhang Y; Ge Y; Lü Z; Li L
    J Transl Med; 2023 Nov; 21(1):851. PubMed ID: 38007511
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biological Misinterpretation of Transcriptional Signatures in Tumor Samples Can Unknowingly Undermine Mechanistic Understanding and Faithful Alignment with Preclinical Data.
    Fisher NC; Byrne RM; Leslie H; Wood C; Legrini A; Cameron AJ; Ahmaderaghi B; Corry SM; Malla SB; Amirkhah R; McCooey AJ; Rogan E; Redmond KL; Sakhnevych S; Domingo E; Jackson J; Loughrey MB; Leedham S; Maughan T; Lawler M; Sansom OJ; Lamrock F; Koelzer VH; Jamieson NB; Dunne PD
    Clin Cancer Res; 2022 Sep; 28(18):4056-4069. PubMed ID: 35792866
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A mouse SWATH-mass spectrometry reference spectral library enables deconvolution of species-specific proteomic alterations in human tumour xenografts.
    Krasny L; Bland P; Burns J; Lima NC; Harrison PT; Pacini L; Elms ML; Ning J; Martinez VG; Yu YR; Acton SE; Ho PC; Calvo F; Swain A; Howard BA; Natrajan RC; Huang PH
    Dis Model Mech; 2020 Jul; 13(7):. PubMed ID: 32493768
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Single-Cell RNA Sequencing Reveals a Dynamic Stromal Niche That Supports Tumor Growth.
    Davidson S; Efremova M; Riedel A; Mahata B; Pramanik J; Huuhtanen J; Kar G; Vento-Tormo R; Hagai T; Chen X; Haniffa MA; Shields JD; Teichmann SA
    Cell Rep; 2020 May; 31(7):107628. PubMed ID: 32433953
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Computational approach to discriminate human and mouse sequences in patient-derived tumour xenografts.
    Callari M; Batra AS; Batra RN; Sammut SJ; Greenwood W; Clifford H; Hercus C; Chin SF; Bruna A; Rueda OM; Caldas C
    BMC Genomics; 2018 Jan; 19(1):19. PubMed ID: 29304755
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High resolution mapping of the tumor microenvironment using integrated single-cell, spatial and in situ analysis.
    Janesick A; Shelansky R; Gottscho AD; Wagner F; Williams SR; Rouault M; Beliakoff G; Morrison CA; Oliveira MF; Sicherman JT; Kohlway A; Abousoud J; Drennon TY; Mohabbat SH; ; Taylor SEB
    Nat Commun; 2023 Dec; 14(1):8353. PubMed ID: 38114474
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integrative Molecular Analyses of the MD Anderson Prostate Cancer Patient-derived Xenograft (MDA PCa PDX) Series.
    Anselmino N; Labanca E; Shepherd PDA; Dong J; Yang J; Song X; Nandakumar S; Kundra R; Lee C; Schultz N; Zhang J; Araujo JC; Aparicio AM; Subudhi SK; Corn PG; Pisters LL; Ward JF; Davis JW; Vazquez ES; Gueron G; Logothetis CJ; Futreal A; Troncoso P; Chen Y; Navone NM
    Clin Cancer Res; 2024 May; 30(10):2272-2285. PubMed ID: 38488813
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modeling stromal-epithelial interactions in disease progression.
    Strand DW; Hayward SW
    Discov Med; 2010 Jun; 9(49):504-11. PubMed ID: 20587339
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Next-Generation Sequencing Analysis and Algorithms for PDX and CDX Models.
    Khandelwal G; Girotti MR; Smowton C; Taylor S; Wirth C; Dynowski M; Frese KK; Brady G; Dive C; Marais R; Miller C
    Mol Cancer Res; 2017 Aug; 15(8):1012-1016. PubMed ID: 28442585
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Maintaining Tumor Heterogeneity in Patient-Derived Tumor Xenografts.
    Cassidy JW; Caldas C; Bruna A
    Cancer Res; 2015 Aug; 75(15):2963-8. PubMed ID: 26180079
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Can stroma reaction predict cancer lethality?
    Freeman MR; Li Q; Chung LW
    Clin Cancer Res; 2013 Sep; 19(18):4905-7. PubMed ID: 24009149
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor-stroma interactions differentially alter drug sensitivity based on the origin of stromal cells.
    Landry BD; Leete T; Richards R; Cruz-Gordillo P; Schwartz HR; Honeywell ME; Ren G; Schwartz AD; Peyton SR; Lee MJ
    Mol Syst Biol; 2018 Aug; 14(8):e8322. PubMed ID: 30082272
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Perspectives on tissue interactions in development and disease.
    Strand DW; Franco OE; Basanta D; Anderson AR; Hayward SW
    Curr Mol Med; 2010 Feb; 10(1):95-112. PubMed ID: 20205682
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The murine Microenvironment Cell Population counter method to estimate abundance of tissue-infiltrating immune and stromal cell populations in murine samples using gene expression.
    Petitprez F; Levy S; Sun CM; Meylan M; Linhard C; Becht E; Elarouci N; Tavel D; Roumenina LT; Ayadi M; Sautès-Fridman C; Fridman WH; de Reyniès A
    Genome Med; 2020 Oct; 12(1):86. PubMed ID: 33023656
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.